Cited by 74Pharmacogenetics and Drug MetabolismMetal-Catalyzed Oxygenation MechanismsDrug Transport and Resistance Mechanisms

Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro

Open access
Sandee, Duanpen, Morrissey, Kari, Agrawal, Vishal, Tam, Harrison K., Kramer, Melissa A., Tracy, Timothy S., Giacomini, Kathleen M., Miller, Walter L.·2010·Pharmacogenetics and Genomics

Abstract

OBJECTIVES: Cytochrome P450 (P450) oxidoreductase (POR) donates electrons to all microsomal cytochrome P450s, including drug-metabolizing and steroidogenic enzymes. Severe POR mutations cause skeletal malformations and disordered steroidogenesis. The POR polymorphism A503V is found on approximately 28% of human alleles and decreases activities of CYP3A4 and steroidogenic CYP17, but not the activities of steroidogenic CYP21 or drug-metabolizing CYP1A2 and CYP2C19. CYP2D6 metabolizes about 25% of clinically used drugs; we assessed the capacity of POR variants to support the activities of human CYP2D6. METHODS: N-27 forms of wildtype (WT), Q153R, A287P, R457H and A503V POR, and WT CYP2D6 were expressed in Escherichia coli. POR proteins in bacterial membranes were reconstituted with purified CYP2D6. Support of CYP2D6 was measured by metabolism of EOMCC (2H-1-benzopyran-3-carbonitrile,7-(ethoxy-methoxy)-2-oxo-(9Cl)), dextromethorphan and bufuralol. Michaelis constant (K(m)) and maximum velocity (V(max)) were determined in three triplicate experiments for each reaction; catalytic efficiency is expressed as V(max)/K(m). RESULTS: Compared with WT POR, disease-causing POR mutants A287P and R457H supported no detectable CYP2D6 activity with EOMCC, but A287P supported approximately 25% activity with dextromethorphan and bufuralol. Q153R had increased function with CYP2D6 (128% with EOMCC, 198% with dextromethorphan, 153% with bufuralol). A503V supported decreased CYP2D6 activity: 85% with EOMCC, 62% with dextromethorphan and 53% with bufuralol. CONCLUSION: POR variants have different effects depending on the substrate metabolized. Disease-causing POR mutations R457H and A287P had poor activities, suggesting that diminished drug metabolism should be considered in affected patients. The common A503V polymorphism impaired CYP2D6 activities with two commonly used drugs by 40-50%, potentially explaining some genetic variation in drug metabolism.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/fpc.0b013e32833f4f9b

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A503V has no measurable effect on the activities of P450c21 or hepatic CYP1A2 or CYP2C19, but it reduces the activities of CYP2D6 and CYP3A4 to metabolize important drugs in vitro.

    “but has no measurable effect on the activities of P450c21 (306) or hepatic CYP1A2 or CYP2C19 (307), but it reduces the activities of CYP2D6 and CYP3A4 to metabolize important drugs in vitro (308, 309).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 48 · Cited by 74

Research works printed but not linked: 1

  1. [27]Agrawal V Choi JH Giacomini KM Miller WL Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase (POR) Pharmacogenet Genomics 2010 in press 10.1097/FPC.0b013e328330cb5 PMC2940949 20697309 · DOI

Authors
Sandee, D., Morrissey, K., Agrawal, V., Tam, H. K., Kramer, M. A., Tracy, T. S., Giacomini, K. M., & Miller, W. L.
Affiliations
  • University of California, San Francisco (US)
  • University of Minnesota (US)
Corresponding author
Miller, Walter L.
Venue
Pharmacogenetics and Genomics
Published
2010-11
Volume
20
Issue
11
Pages
677-686
ISSN
1744-6872 (ISSN-L)
OpenAlex
W2040081769
Cited by
74
References
48
Citations by year
2026: 1 · 2025: 1 · 2024: 4 · 2023: 4 · 2022: 4 · 2021: 2 · 2020: 2 · 2019: 4 · 2018: 5 · 2017: 4 · 2016: 7 · 2015: 9 · 2014: 5 · 2013: 10 · 2012: 7
FWCI
7.08
Type
journal article
Language
en
Open access
Locations
  • Pharmacogenetics and Genomics (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of General Medical Sciences (R01GM073020, R01GM069753, T32GM007175, U01GM061390)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Physical Sciences › Chemistry › Inorganic Chemistry › Metal-Catalyzed Oxygenation Mechanisms
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords
cytochrome P450 oxidoreductase, CYP2D6, electron transfer, drug metabolism, dextromethorphan, bufuralol, steroidogenesis, catalytic efficiency
MeSH terms
Benzopyrans, Catalysis, Dextromethorphan, Ethanolamines, Humans, Inactivation, Metabolic, Mutation, NADPH-Ferrihemoprotein Reductase, Oxidoreductases, Polymorphism, Genetic, Genetic Variation, Cytochrome P-450 CYP2D6

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review